Skip to content
HowShorted

CYPHERPUNK TECHNOLOGIES INC. short interest in 2024

In 2024, CYPHERPUNK TECHNOLOGIES INC.'s disclosed short interest ran from 2.34% of shares outstanding on 12 Jan 2024 to 5.71% on 31 Dec 2024, a change of +3.37 percentage points. The year's high was 5.71% on 31 Dec 2024 and its low 1.89% on 15 Oct 2024, averaging 3.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.37 days on 13 Sep 2024. Full history: CYPHERPUNK TECHNOLOGIES INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CYPHERPUNK TECHNOLOGIES INC. in 2024

2024 in figures

Start of year
2.34% (12 Jan 2024)
End of year
5.71% (31 Dec 2024)
Change
+3.37 pp
High
5.71% (31 Dec 2024)
Low
1.89% (15 Oct 2024)
Average
3.99%
Highest days to cover
16.37 (13 Sep 2024)
SEC filings marked
8

Every report in 2024

CYPHERPUNK TECHNOLOGIES INC. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20242.34%1.89
31 Jan 20242.51%2.18
15 Feb 20244.40%5.09
29 Feb 20244.59%5.73
15 Mar 20244.40%6.23
28 Mar 20244.44%5.8010-K filed, results (8-K)
15 Apr 20245.67%1.76
30 Apr 20245.32%7.25
15 May 20245.27%6.7210-Q filed, results (8-K)
31 May 20245.02%6.50
14 Jun 20244.86%8.65
28 Jun 20244.14%6.66
15 Jul 20244.41%8.87
31 Jul 20244.12%11.99
15 Aug 20243.22%10.8910-Q filed, results (8-K)
30 Aug 20242.72%9.69
13 Sep 20242.65%16.37
30 Sep 20242.35%4.69
15 Oct 20241.89%8.05
31 Oct 20242.64%1.58
15 Nov 20243.71%4.8810-Q filed, results (8-K)
29 Nov 20243.72%4.70
13 Dec 20245.59%3.81
31 Dec 20245.71%9.62

See also: CYPHERPUNK TECHNOLOGIES INC.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.